Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Corcept's President, Corcept Endocrinology Justin Frederick Gunn filed a Form 3 showing 12,191 shares of common stock. Disclosure also lists stock options covering 72,397 shares, with exercise prices of $35.7, $37.94, $60.58.
Corcept Therapeutics submits regulatory filing with the SEC. The filing may contain information on the company's financials or operations.
Corcept Therapeutics submits regulatory filing to SEC. The filing may contain information on the company's financials or operations.